Annual Total Long Term Liabilities
$5.68 B
+$381.01 M+7.19%
31 December 2023
Summary:
Novo Nordisk A/S annual total long term liabilities is currently $5.68 billion, with the most recent change of +$381.01 million (+7.19%) on 31 December 2023. During the last 3 years, it has risen by +$3.81 billion (+203.58%). NVO annual total long term liabilities is now at all-time high.NVO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$10.27 B
+$371.01 M+3.75%
30 September 2024
Summary:
Novo Nordisk A/S quarterly total long term liabilities is currently $10.27 billion, with the most recent change of +$371.01 million (+3.75%) on 30 September 2024. Over the past year, it has increased by +$5.37 billion (+109.81%). NVO quarterly long term liabilities is now at all-time high.NVO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.2% | +109.8% |
| 3 y3 years | +203.6% | +235.1% |
| 5 y5 years | +678.3% | +690.2% |
NVO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +203.6% | at high | +235.1% |
| 5 y | 5 years | at high | +678.3% | at high | +702.0% |
| alltime | all time | at high | +9486.0% | at high | >+9999.0% |
Novo Nordisk A/S Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $10.27 B(+3.7%) |
| June 2024 | - | $9.90 B(+98.9%) |
| Mar 2024 | - | $4.98 B(-12.4%) |
| Dec 2023 | $5.68 B(+7.2%) | $5.68 B(+16.1%) |
| Sept 2023 | - | $4.89 B(-0.4%) |
| June 2023 | - | $4.91 B(-12.1%) |
| Mar 2023 | - | $5.59 B(+5.5%) |
| Dec 2022 | $5.30 B(+43.6%) | $5.30 B(+11.7%) |
| Sept 2022 | - | $4.74 B(-2.9%) |
| June 2022 | - | $4.89 B(-6.9%) |
| Mar 2022 | - | $5.25 B(+42.2%) |
| Dec 2021 | $3.69 B(+97.2%) | $3.69 B(+20.4%) |
| Sept 2021 | - | $3.06 B(-3.0%) |
| June 2021 | - | $3.16 B(+90.7%) |
| Mar 2021 | - | $1.66 B(-11.5%) |
| Dec 2020 | $1.87 B(+38.2%) | $1.87 B(+25.9%) |
| Sept 2020 | - | $1.49 B(+12.2%) |
| June 2020 | - | $1.32 B(+3.5%) |
| Mar 2020 | - | $1.28 B(-5.5%) |
| Dec 2019 | $1.35 B(+85.5%) | $1.35 B(+4.2%) |
| Sept 2019 | - | $1.30 B(+3.7%) |
| June 2019 | - | $1.25 B(+3.6%) |
| Mar 2019 | - | $1.21 B(+65.8%) |
| Dec 2018 | $730.10 M(-17.4%) | $730.10 M(-5.4%) |
| Sept 2018 | - | $771.42 M(-0.3%) |
| June 2018 | - | $773.74 M(-9.2%) |
| Mar 2018 | - | $851.73 M(-3.6%) |
| Dec 2017 | $883.75 M(+28.6%) | $883.75 M(-4.0%) |
| Sept 2017 | - | $920.87 M(+7.6%) |
| June 2017 | - | $856.06 M(+19.0%) |
| Mar 2017 | - | $719.54 M(+4.7%) |
| Dec 2016 | $687.44 M(+18.6%) | $687.44 M(+3.3%) |
| Sept 2016 | - | $665.36 M(+7.1%) |
| June 2016 | - | $621.41 M(+1.9%) |
| Mar 2016 | - | $609.68 M(+5.2%) |
| Dec 2015 | $579.62 M(+15.3%) | $579.62 M(+7.8%) |
| Sept 2015 | - | $537.44 M(-0.9%) |
| June 2015 | - | $542.54 M(+11.4%) |
| Mar 2015 | - | $487.10 M(-3.1%) |
| Dec 2014 | $502.71 M(-23.3%) | $502.71 M(-10.2%) |
| Sept 2014 | - | $559.96 M(-6.5%) |
| June 2014 | - | $598.61 M(-0.3%) |
| Mar 2014 | - | $600.45 M(-8.4%) |
| Dec 2013 | $655.77 M(+8.9%) | $655.77 M(+8.2%) |
| Sept 2013 | - | $606.12 M(-1.2%) |
| June 2013 | - | $613.65 M(+18.2%) |
| Mar 2013 | - | $519.05 M(-13.8%) |
| Dec 2012 | $602.44 M(-46.6%) | $602.44 M(-26.5%) |
| Sept 2012 | - | $819.69 M(-15.4%) |
| June 2012 | - | $969.18 M(-21.0%) |
| Mar 2012 | - | $1.23 B(+8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $1.13 B(+6.0%) | $1.13 B(-0.8%) |
| Sept 2011 | - | $1.14 B(-1.7%) |
| June 2011 | - | $1.16 B(+2.2%) |
| Mar 2011 | - | $1.13 B(+6.4%) |
| Dec 2010 | $1.06 B(-1.2%) | $1.06 B(-2.5%) |
| Sept 2010 | - | $1.09 B(+29.7%) |
| June 2010 | - | $841.27 M(-18.9%) |
| Mar 2010 | - | $1.04 B(-3.6%) |
| Dec 2009 | $1.08 B(+22.5%) | $1.08 B(+14.4%) |
| Sept 2009 | - | $940.47 M(+6.5%) |
| June 2009 | - | $883.03 M(+5.3%) |
| Mar 2009 | - | $838.90 M(-4.5%) |
| Dec 2008 | $878.35 M(-8.6%) | $878.35 M(+3.4%) |
| Sept 2008 | - | $849.20 M(-8.8%) |
| June 2008 | - | $931.52 M(-5.7%) |
| Mar 2008 | - | $988.29 M(+2.8%) |
| Dec 2007 | $961.09 M(+23.3%) | $961.09 M(+11.8%) |
| Sept 2007 | - | $859.52 M(+10.3%) |
| June 2007 | - | $779.00 M(-1.5%) |
| Mar 2007 | - | $791.00 M(+1.5%) |
| Dec 2006 | $779.55 M(+31.5%) | $779.55 M(+15.5%) |
| Sept 2006 | - | $675.00 M(-1.8%) |
| June 2006 | - | $687.42 M(+12.8%) |
| Mar 2006 | - | $609.33 M(+2.8%) |
| Dec 2005 | $593.00 M(-11.4%) | $593.00 M(-13.8%) |
| Sept 2005 | - | $687.62 M(+34.2%) |
| June 2005 | - | $512.26 M(-11.6%) |
| Mar 2005 | - | $579.32 M(-13.4%) |
| Dec 2004 | $669.34 M(+55.3%) | $669.34 M(+51.1%) |
| Sept 2004 | - | $443.10 M(+2.4%) |
| June 2004 | - | $432.52 M(-6.3%) |
| Mar 2004 | - | $461.69 M(+7.1%) |
| Dec 2003 | $431.01 M(+17.5%) | $431.01 M(+17.5%) |
| Dec 2002 | $366.68 M(+12.2%) | $366.68 M(+12.2%) |
| Dec 2001 | $326.71 M(+7.8%) | $326.71 M(+7.8%) |
| Dec 2000 | $303.03 M(-0.8%) | $303.03 M(-0.8%) |
| Dec 1999 | $305.33 M(-49.0%) | $305.33 M(-49.0%) |
| Dec 1998 | $598.57 M(+85.7%) | $598.57 M(+85.7%) |
| Dec 1997 | $322.29 M(+41.8%) | $322.29 M(+41.8%) |
| Dec 1996 | $227.23 M(-29.4%) | $227.23 M(-29.4%) |
| Dec 1995 | $322.08 M(-42.7%) | $322.08 M(-42.7%) |
| Dec 1994 | $561.81 M(+5.8%) | $561.81 M(+5.8%) |
| Dec 1993 | $530.95 M(+18.8%) | $530.95 M(+18.8%) |
| Dec 1992 | $447.01 M(+38.1%) | $447.01 M(+38.1%) |
| Dec 1991 | $323.71 M(+43.6%) | $323.71 M(+43.6%) |
| Dec 1990 | $225.37 M(-15.0%) | $225.37 M(-15.0%) |
| Dec 1989 | $265.19 M(+87.6%) | $265.19 M(+87.6%) |
| Dec 1988 | $141.34 M(-12.3%) | $141.34 M(-12.3%) |
| Dec 1987 | $161.14 M(-37.0%) | $161.14 M(-37.0%) |
| Dec 1986 | $255.73 M(+171.9%) | $255.73 M(+171.9%) |
| Dec 1985 | $94.04 M(+58.7%) | $94.04 M(+58.7%) |
| Dec 1984 | $59.27 M | $59.27 M |
FAQ
- What is Novo Nordisk A/S annual total long term liabilities?
- What is the all time high annual total long term liabilities for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual total long term liabilities year-on-year change?
- What is Novo Nordisk A/S quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly long term liabilities year-on-year change?
What is Novo Nordisk A/S annual total long term liabilities?
The current annual total long term liabilities of NVO is $5.68 B
What is the all time high annual total long term liabilities for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual total long term liabilities is $5.68 B
What is Novo Nordisk A/S annual total long term liabilities year-on-year change?
Over the past year, NVO annual total long term liabilities has changed by +$381.01 M (+7.19%)
What is Novo Nordisk A/S quarterly total long term liabilities?
The current quarterly long term liabilities of NVO is $10.27 B
What is the all time high quarterly long term liabilities for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly total long term liabilities is $10.27 B
What is Novo Nordisk A/S quarterly long term liabilities year-on-year change?
Over the past year, NVO quarterly total long term liabilities has changed by +$5.37 B (+109.81%)